Skip to main content
Clinical Trials/ISRCTN12302923
ISRCTN12302923Completed未知

Oral paracetamol versus oral ibuprofen for the treatment of patent ductus arteriosus in preterm infants: A randomized trial

niversity of Jordan0 sites10 target enrollmentStarted: February 17, 2017Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Premature infants born 32 weeks gestation or earlier
  • 2. Newborns with birth weight 1500 g or under

Exclusion Criteria

  • 1. Ductal dependent congenital heart diseases
  • 2. Major congenital malformation
  • 3. Grade 3-4 intraventricular hemorrhage
  • 4. Renal impairment defined as Creatinine > 1.5 mg/dl
  • 5. Pulmonary hemorrhage
  • 6. Thrombocytopenia < 60.000 /mm 3
  • 7. Elevated Alanine transaminase (ALT)

Investigators

Sponsor
niversity of Jordan

Similar Trials

Patent ductus arteriosus (PDA) treatment... | Clinical Trial